90 related articles for article (PubMed ID: 34020222)
1. Development of 6E3 antibody-mediated SERS immunoassay for drug-resistant influenza virus.
Kim H; Kang H; Kim HN; Kim H; Moon J; Guk K; Park H; Yong D; Bae PK; Park HG; Lim EK; Kang T; Jung J
Biosens Bioelectron; 2021 Sep; 187():113324. PubMed ID: 34020222
[TBL] [Abstract][Full Text] [Related]
2. Superb Specific, Ultrasensitive, and Rapid Identification of the Oseltamivir-Resistant H1N1 Virus: Naked-Eye and SERS Dual-Mode Assay Using Functional Gold Nanoparticles.
Eom G; Hwang A; Lee DK; Guk K; Moon J; Jeong J; Jung J; Kim B; Lim EK; Kang T
ACS Appl Bio Mater; 2019 Mar; 2(3):1233-1240. PubMed ID: 35021372
[TBL] [Abstract][Full Text] [Related]
3. Development of A4 antibody for detection of neuraminidase I223R/H275Y-associated antiviral multidrug-resistant influenza virus.
Guk K; Kim H; Lee M; Choi YA; Hwang SG; Han G; Kim HN; Kim H; Park H; Yong D; Kang T; Lim EK; Jung J
Nat Commun; 2020 Jul; 11(1):3418. PubMed ID: 32647286
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro.
Gubareva LV; Trujillo AA; Okomo-Adhiambo M; Mishin VP; Deyde VM; Sleeman K; Nguyen HT; Sheu TG; Garten RJ; Shaw MW; Fry AM; Klimov AI
Antivir Ther; 2010; 15(8):1151-9. PubMed ID: 21149922
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of Tamiflu-Resistant Influenza Virus in Human Nasal Fluid and Saliva Using Surface-Enhanced Raman Scattering.
Eom G; Hwang A; Kim H; Yang S; Lee DK; Song S; Ha K; Jeong J; Jung J; Lim EK; Kang T
ACS Sens; 2019 Sep; 4(9):2282-2287. PubMed ID: 31407570
[TBL] [Abstract][Full Text] [Related]
6. Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009-2011.
Yang JR; Huang YP; Chang FY; Hsu LC; Huang HY; Pan YT; Lin YC; Wu HS; Liu MT
J Med Virol; 2013 Mar; 85(3):379-87. PubMed ID: 23280715
[TBL] [Abstract][Full Text] [Related]
7. Neuraminidase Activity and Resistance of 2009 Pandemic H1N1 Influenza Virus to Antiviral Activity in Bronchoalveolar Fluid.
Ruangrung K; Suptawiwat O; Maneechotesuwan K; Boonarkart C; Chakritbudsabong W; Assawabhumi J; Bhattarakosol P; Uiprasertkul M; Puthavathana P; Wiriyarat W; Jongkaewwattana A; Auewarakul P
J Virol; 2016 May; 90(9):4637-4646. PubMed ID: 26912622
[TBL] [Abstract][Full Text] [Related]
8. Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States.
Nguyen HT; Trujillo AA; Sheu TG; Levine M; Mishin VP; Shaw M; Ades EW; Klimov AI; Fry AM; Gubareva LV
Antiviral Res; 2012 Mar; 93(3):381-6. PubMed ID: 22330888
[TBL] [Abstract][Full Text] [Related]
9. An I436N substitution confers resistance of influenza A(H1N1)pdm09 viruses to multiple neuraminidase inhibitors without affecting viral fitness.
Kwon JJ; Choi WS; Jeong JH; Kim EH; Lee OJ; Yoon SW; Hwang J; Webby RJ; Govorkova EA; Choi YK; Baek YH; Song MS
J Gen Virol; 2018 Mar; 99(3):292-302. PubMed ID: 29493493
[TBL] [Abstract][Full Text] [Related]
10. Characterization of neuraminidase inhibitor-resistant influenza virus isolates from immunocompromised patients in the Republic of Korea.
Kim HM; Lee N; Kim MS; Kang C; Chung YS
Virol J; 2020 Jul; 17(1):94. PubMed ID: 32631440
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of Brazilian influenza A(H1N1)pdm09 viruses to neuraminidase inhibitors in the 2014-2016 seasons: Identification of strains bearing mutations associated with reduced inhibition profile.
Matos AR; Resende PC; Miranda MD; Garcia CC; Caetano BC; Lopes JCO; Debur MC; Cury ALF; Vianna LA; Lima MC; Schirmer M; Gubareva L; Hurt AC; Brown DW; Siqueira MM
Antiviral Res; 2018 Jun; 154():35-43. PubMed ID: 29601892
[TBL] [Abstract][Full Text] [Related]
12. Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010.
Meijer A; Jonges M; Abbink F; Ang W; van Beek J; Beersma M; Bloembergen P; Boucher C; Claas E; Donker G; van Gageldonk-Lafeber R; Isken L; de Jong A; Kroes A; Leenders S; van der Lubben M; Mascini E; Niesters B; Oosterheert JJ; Osterhaus A; Riesmeijer R; Riezebos-Brilman A; Schutten M; Sebens F; Stelma F; Swaan C; Timen A; van 't Veen A; van der Vries E; te Wierik M; Koopmans M
Antiviral Res; 2011 Oct; 92(1):81-9. PubMed ID: 21767571
[TBL] [Abstract][Full Text] [Related]
13. Persistence of pandemic influenza H1N1 virus in young patients after oseltamivir therapy in the 2009-2010 season: a comparison with seasonal H1N1 with or without H275Y mutation.
Kawai N; Ikematsu H; Iwaki N; Kondou K; Hirotsu N; Kawashima T; Maeda T; Tanaka O; Doniwa K; Iwakuni O; Egashira K; Yamaji K; Kashiwagi S
J Infect Chemother; 2012 Apr; 18(2):180-6. PubMed ID: 22193710
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of an allele-specific reverse transcriptase-PCR assay targeting the H275Y oseltamivir resistant mutation in 2009 pandemic influenza A/H1N1 virus.
Renaud C; Kuypers J; Corey L
J Clin Virol; 2010 Sep; 49(1):21-5. PubMed ID: 20674476
[TBL] [Abstract][Full Text] [Related]
15. Early findings of oseltamivir-resistant pandemic (H1N1) 2009 influenza A viruses in Taiwan.
Yang JR; Huang YP; Lin YC; Su CH; Kuo CY; Hsu LC; Wu HS; Liu MT
Antiviral Res; 2010 Dec; 88(3):256-62. PubMed ID: 20869989
[TBL] [Abstract][Full Text] [Related]
16. Permissive changes in the neuraminidase play a dominant role in improving the viral fitness of oseltamivir-resistant seasonal influenza A(H1N1) strains.
Abed Y; Pizzorno A; Bouhy X; Boivin G
Antiviral Res; 2015 Feb; 114():57-61. PubMed ID: 25512229
[TBL] [Abstract][Full Text] [Related]
17. Allele-specific conventional reverse-transcription polymerase chain reaction as a screening assay for discriminating influenza a H1N1 (H275Y) oseltamivir-resistant and wild-type viruses.
Ngai KL; Lam WY; Lee N; Leung TF; Hui DS; Chan PK
J Med Virol; 2010 Aug; 82(8):1295-8. PubMed ID: 20572070
[TBL] [Abstract][Full Text] [Related]
18. Frequency of oseltamivir resistance in Sydney, during the Newcastle outbreak of community transmitted oseltamivir-resistant influenza A(H1N1)pdm09 virus, Australia, June to August 2011.
Wang B; Taylor J; Ratnamohan M; McPhie K; Kesson A; Dixit R; Booy R; Hurt A; Saksena N; Dwyer DE
Euro Surveill; 2012 Jul; 17(27):. PubMed ID: 22790606
[TBL] [Abstract][Full Text] [Related]
19. Kinetic, Thermodynamic, and Structural Analysis of Drug Resistance Mutations in Neuraminidase from the 2009 Pandemic Influenza Virus.
Pokorná J; Pachl P; Karlukova E; Hejdánek J; Řezáčová P; Machara A; Hudlický J; Konvalinka J; Kožíšek M
Viruses; 2018 Jun; 10(7):. PubMed ID: 29933553
[TBL] [Abstract][Full Text] [Related]
20. Epidemiological and genetic characterization of pH1N1 and H3N2 influenza viruses circulated in MENA region during 2009-2017.
Al Khatib HA; Al Thani AA; Gallouzi I; Yassine HM
BMC Infect Dis; 2019 Apr; 19(1):314. PubMed ID: 30971204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
